Therapeutic Options in Myelodysplastic Syndromes: Established and Emerging Therapies

Therapeutic Options in Myelodysplastic Syndromes: Established and Emerging Therapies

Although hypomethylating agents (HMA) have revolutionised the treatment of myelodysplastic syndromes (MDS), a significant proportion of patients either fail to respond to HMA or their disease progresses after an initial response. Established therapeutic options for these patients remain limited. For...

Full description

Bibliographic Details
Main Authors: Nina Kim, Shyamala Navada
Format: Article
Language:English
Published: European Medical Journal 2018-08-01
Series:European Medical Journal Hematology
Subjects:
hypomethylating agents (hma)
myelodysplastic syndromes (mds)
novel therapies
targeted therapies
treatment
Online Access:https://www.emjreviews.com/hematology/article/therapeutic-options-in-myelodysplastic-syndromes-established-and-emerging-therapies/

Internet

https://www.emjreviews.com/hematology/article/therapeutic-options-in-myelodysplastic-syndromes-established-and-emerging-therapies/

Similar Items